GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tactile Systems Technology Inc (NAS:TCMD) » Definitions » Days Sales Outstanding

Tactile Systems Technology (Tactile Systems Technology) Days Sales Outstanding : 51.15 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Tactile Systems Technology Days Sales Outstanding?

Tactile Systems Technology's average Accounts Receivable for the three months ended in Dec. 2023 was $43.5 Mil. Tactile Systems Technology's Revenue for the three months ended in Dec. 2023 was $77.7 Mil. Hence, Tactile Systems Technology's Days Sales Outstanding for the three months ended in Dec. 2023 was 51.15.

The historical rank and industry rank for Tactile Systems Technology's Days Sales Outstanding or its related term are showing as below:

TCMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.26   Med: 70.28   Max: 89.13
Current: 63.7

During the past 11 years, Tactile Systems Technology's highest Days Sales Outstanding was 89.13. The lowest was 53.26. And the median was 70.28.

TCMD's Days Sales Outstanding is ranked better than
50.19% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs TCMD: 63.70

Tactile Systems Technology's Days Sales Outstanding declined from Dec. 2022 (65.84) to Dec. 2023 (51.15).


Tactile Systems Technology Days Sales Outstanding Historical Data

The historical data trend for Tactile Systems Technology's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tactile Systems Technology Days Sales Outstanding Chart

Tactile Systems Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.64 75.38 81.86 77.13 65.17

Tactile Systems Technology Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.84 82.07 65.14 59.29 51.15

Competitive Comparison of Tactile Systems Technology's Days Sales Outstanding

For the Medical Devices subindustry, Tactile Systems Technology's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tactile Systems Technology's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Tactile Systems Technology's Days Sales Outstanding falls into.



Tactile Systems Technology Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Tactile Systems Technology's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (54.826 + 43.173) / 2 ) / 274.423*365
=48.9995 / 274.423*365
=65.17

Tactile Systems Technology's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (43.879 + 43.173) / 2 ) / 77.652*365 / 4
=43.526 / 77.652*365 / 4
=51.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tactile Systems Technology  (NAS:TCMD) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Tactile Systems Technology Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Tactile Systems Technology's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Tactile Systems Technology (Tactile Systems Technology) Business Description

Traded in Other Exchanges
Address
3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
Executives
Boyd Vindell Washington director 1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
Daniel L. Reuvers director, officer: President and CEO INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Sherri Lee Ferstler officer: Senior VP, Sales 1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
William W Burke director 3868 MOCKINGBIRD LN, DALLAS TX 75205
Kristie Burns officer: Sr. VP Mktg & Clinical Affairs 3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Eric Pauls officer: Senior VP, Sales 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Elaine M. Birkemeyer officer: Chief Financial Officer 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Brent Moen officer: Chief Financial Officer 3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Carmen B Volkart director C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Valerie L. Asbury director 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
David Brent Shafer director 2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Bryan Rishe officer: Vice President, Sales 1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Deepti Jain director 3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sheri Louise Dodd director 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Gerald R. Mattys director, officer: Chief Executive Officer 1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413